|
|
|
Volumn 13, Issue 1, 1998, Pages 7-20
|
|
New perspectives for the treatment of HIV infections
|
|
Author keywords
AIDS; CXCR4; HIV; NNRTIs; NRTIs; PMEA; PMPA
|
|
Indexed keywords
1,1' [1,4 PHENYLENE BIS(METHYLENE)] BIS 1,4,8,11 TETRA AZACYCLOTETRADECANE;
3 [(4,7 DICHLORO 2 BENZOXAZOLYLMETHYL)AMINO] 5 ETHYL 6 METHYL 2(1H) PYRIDONE;
ABACAVIR;
ACYCLIC NUCLEOSIDE;
ADEFOVIR DIPIVOXIL;
AMPRENAVIR;
BENZOXAZINONE DERIVATIVE;
DELAVIRDINE;
DIDANOSINE;
EFAVIRENZ;
EMIVIRINE;
INDINAVIR;
LAMIVUDINE;
LASINAVIR;
LOPINAVIR;
LOVIRIDE;
MOZENAVIR;
N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE;
NELFINAVIR;
NEVIRAPINE;
PALINAVIR;
PNU 14690;
PROTEINASE INHIBITOR;
PYRIDONE DERIVATIVE;
QUINOXALINE;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
TALVIRALINE;
THIOCARBOXANILIDE;
TIVIRAPINE;
TROVIRDINE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ZALCITABINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
DISEASE COURSE;
DRUG ACTIVITY;
DRUG MECHANISM;
DRUG METABOLISM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PRACTICE GUIDELINE;
TREATMENT PLANNING;
VIRUS ADSORPTION;
|
|
EID: 0031849572
PISSN: 0394025X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (33)
|
